Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Xenazine current manufacturer 2025?
When genetic tenofovir alafenamide be available in us?
Cost promethazine price?
Can i take anti histamine with statin?
Somatuline generic name?

Acalabrutinib approval date?

See the DrugPatentWatch profile for Acalabrutinib

Acalabrutinib (brand name Brukinsa) was first approved by the U.S. Food and Drug Administration on December 20, 2019 for treatment of chronic lymphocytic leukemia (CLL) and later also for mantle cell lymphoma (MCL).



Other Questions About Acalabrutinib :

Acalabrutinib cost? Acalabrutinib first fda approval date? Cost of acalabrutinib? Acalabrutinib market? Acalabrutinib fda approval date calquence? Acalabrutinib fda approval october 31 2017? Acalabrutinib fda approval date 2017 calquence?